460 related articles for article (PubMed ID: 21801601)
1. Mitochondria in cancer: at the crossroads of life and death.
Fogg VC; Lanning NJ; Mackeigan JP
Chin J Cancer; 2011 Aug; 30(8):526-39. PubMed ID: 21801601
[TBL] [Abstract][Full Text] [Related]
2. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
Lu J; Tan M; Cai Q
Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
[TBL] [Abstract][Full Text] [Related]
3. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
[TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
5. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
Vaupel P; Schmidberger H; Mayer A
Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
[TBL] [Abstract][Full Text] [Related]
6. The crosstalk between HIFs and mitochondrial dysfunctions in cancer development.
Bao X; Zhang J; Huang G; Yan J; Xu C; Dou Z; Sun C; Zhang H
Cell Death Dis; 2021 Feb; 12(2):215. PubMed ID: 33637686
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations in Krebs cycle and its impact on cancer pathogenesis.
Sajnani K; Islam F; Smith RA; Gopalan V; Lam AK
Biochimie; 2017 Apr; 135():164-172. PubMed ID: 28219702
[TBL] [Abstract][Full Text] [Related]
8. HIF-1-mediated metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of cancers in lungs.
Zhao T; Zhu Y; Morinibu A; Kobayashi M; Shinomiya K; Itasaka S; Yoshimura M; Guo G; Hiraoka M; Harada H
Sci Rep; 2014 Jan; 4():3793. PubMed ID: 24452734
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria and reactive oxygen species in renal cancer.
Hervouet E; Simonnet H; Godinot C
Biochimie; 2007 Sep; 89(9):1080-8. PubMed ID: 17466430
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria and cancer: Warburg addressed.
Wallace DC
Cold Spring Harb Symp Quant Biol; 2005; 70():363-74. PubMed ID: 16869773
[TBL] [Abstract][Full Text] [Related]
11. Micromanaging aerobic respiration and glycolysis in cancer cells.
Orang AV; Petersen J; McKinnon RA; Michael MZ
Mol Metab; 2019 May; 23():98-126. PubMed ID: 30837197
[TBL] [Abstract][Full Text] [Related]
12. Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites.
Menendez JA; Alarcón T; Joven J
Cell Cycle; 2014; 13(5):699-709. PubMed ID: 24526120
[TBL] [Abstract][Full Text] [Related]
13. Relevance of mitochondrial genetics and metabolism in cancer development.
Gasparre G; Porcelli AM; Lenaz G; Romeo G
Cold Spring Harb Perspect Biol; 2013 Feb; 5(2):. PubMed ID: 23378588
[TBL] [Abstract][Full Text] [Related]
14. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor WWOX moderates the mitochondrial respiratory complex.
Choo A; O'Keefe LV; Lee CS; Gregory SL; Shaukat Z; Colella A; Lee K; Denton D; Richards RI
Genes Chromosomes Cancer; 2015 Dec; 54(12):745-61. PubMed ID: 26390919
[TBL] [Abstract][Full Text] [Related]
16. Role of mitochondrial dysfunction in cancer progression.
Hsu CC; Tseng LM; Lee HC
Exp Biol Med (Maywood); 2016 Jun; 241(12):1281-95. PubMed ID: 27022139
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial metabolism-mediated redox regulation in cancer progression.
Boese AC; Kang S
Redox Biol; 2021 Jun; 42():101870. PubMed ID: 33509708
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia, HIF1 and glucose metabolism in the solid tumour.
Denko NC
Nat Rev Cancer; 2008 Sep; 8(9):705-13. PubMed ID: 19143055
[TBL] [Abstract][Full Text] [Related]
19. Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect.
Lu CL; Qin L; Liu HC; Candas D; Fan M; Li JJ
PLoS One; 2015; 10(3):e0121046. PubMed ID: 25807077
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity.
Desideri E; Vegliante R; Ciriolo MR
Cancer Lett; 2015 Jan; 356(2 Pt A):217-23. PubMed ID: 24614286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
